Y-Intercept (Hong Kong) Ltd
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1772875
HONG KONG, K3
Position in ADPT
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$2,898,688
+$2,898,688 QoQ
Shares Held
33,784
+468.4% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#7
of 70 holders
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $30,838,073 across 12 Diagnostics & Research names. ADPT ranks #4 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
16,330 | $8,596,765 | |
| 2 | GH |
Guardant Health, Inc.
|
52,547 | $7,883,626 | |
| 3 | ILMN |
Illumina, Inc.
|
18,655 | $3,280,108 | |
| 4 | ADPT |
Adaptive Biotechnologies Corp
This page
|
33,784 | $2,898,688 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
10,950 | $2,115,759 | |
| 6 | WGS |
GeneDx Holdings Corp.
|
27,521 | $1,889,316 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
2,669 | $1,338,129 | |
| 8 | LH |
Labcorp Holdings Inc.
|
4,074 | $1,140,720 |
All Filings in ADPT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,898,688 | 135,137 | Shares | Sole | 2026-07-14 | |
| 2025-12-31 | — | 23,777 | Shares | Sole | 2026-02-13 | |
| 2024-06-30 | — | 67,252 | Shares | Sole | 2024-08-14 | |
| 2023-06-30 | — | 18,310 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | — | 27,126 | Shares | Sole | 2023-05-09 | |
| 2022-03-31 | — | 14,876 | Shares | Sole | 2022-05-16 | |
| 2021-03-31 | — | 8,040 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | — | 4,393 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||